Seeing Is Believing
Currently out of the existing stock ratings of Jason Wittes, 76 are a BUY (85.39%), 13 are a HOLD (14.61%).
Analyst Jason Wittes, carries an average stock price target met ratio of 54.9% that have a potential upside of 32.96% achieved within 249 days. Previously, Jason Wittes worked at NORTHLAND CAPITAL MARKETS, AEGIS, BREAN.
Jason Wittes’s has documented 166 price targets and ratings displayed on 21 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SYK, Stryker at 02-May-2025.
Analyst best performing recommendations are on PGNX (PROGENICS PHARMACEUTICALS).
The best stock recommendation documented was for BWAY (BRAINSWAY LTD) at 8/10/2023. The price target of $5.5 was fulfilled within 104 days with a profit of $2.8 (103.7%) receiving and performance score of 9.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$9
$7.31 (432.54%)
1 years 7 months 27 days ago
(12-Feb-2024)
0/3 (0%)
$6.25 (227.27%)
Buy
$7
$5.31 (314.20%)
$9.5
3 years 3 months 16 days ago
(23-Jun-2022)
0/2 (0%)
$4.94 (239.81%)
Buy
$10
$8.31 (491.72%)
$10
3 years 11 months 14 days ago
(25-Oct-2021)
0/5 (0%)
$5.7 (132.56%)
Hold
$4.25
$2.56 (151.48%)
$4
6 years 3 months ago
(09-Jul-2019)
3/3 (100%)
$0.59 (16.12%)
99
Which stock is Jason Wittes is most bullish on?
What Year was the first public recommendation made by Jason Wittes?